

Interdisciplinary
Oncology Program

Clinical Research and Nursing

Dr. Jennifer Baumbusch
Clinical Research and Nursing
Dr. Baumbusch directs a research programme on health care delivery and nursing practice with older adults. Her focus is in long-term residential care, family contributions to care delivery, well-being among individuals with intellectual disabilities and their families, and knowledge translation. She has expertise in critical ethnography and practice-close research. Jennifer is committed to community-based research principles through active engagement of individuals, clinicians, service providers, and organizations.

Dr. Kristin Campbell
Kristin Campbell, BSc, PT, PhD is a licensed physical therapist and Professor in the Department of Physical Therapy at the University of British Columbia. She also holds an appointment in Cancer Control at the BC Cancer Research Institute. She completed her PhD in exercise physiology at the University of Alberta and a Fellowship in Public Health at the Fred Hutchinson Cancer Research Centre. Her research focus is on the role of exercise and energy balance in cancer prevention, rehabilitation and survivorship. Dr. Campbell is the author of over 165 peer reviewed articles and academic book chapters and she participates on national and international advisory boards and grant review panels on cancer prevention, rehabiliation and survivorship. In 2020, she received a Distinguished Achievement Award for Overall Excellence Mid-Career from the Faculty of Medicine at UBC and a Visiting Scholar Award from the American College of Sports Medicine in 2022.

Dr. Martin Gleave
Dr. Gleave is a clinician-scientist and urologic surgeon whose clinical practice focuses on urologic oncology in a multi-disciplinary environment at the leading edge of assessing new technologies and treatments across both localized and advanced cancers. His research characterizes molecular mechanisms mediating treatment resistance in cancer, focusing on adaptive survival responses that drive acquired treatment resistance, and designing combination co-targeting strategies to create conditional lethality and improve cancer control. He patented several anti-cancer drugs and in 2001 founded OncoGenex Pharmaceuticals to develop OGX-011 and OGX-427, inhibitors of cytoprotective chaperones clusterin and Hsp27 now in Phase III and Phase II trials world-wide. He has co-founded several other companies including Sitka Pharma, TRiADD, and Sustained Therapeutics.

Dr. Kristen Haase
My research program centres on understanding the experiences of older adults as they manage cancer, chronic disease, and wellbeing. I have two main interests: (1) supporting older adults with cancer and their carers and (2) leveraging technology to support people with cancer and other chronic diseases. The goal of my program of research is to engage older adults with lived experience of cancer and chronic disease to co-lead the development of community-based interventions to improve quality of life and wellbeing amongst older adults and their caregivers.

Dr. Fuchsia A. Howard
Clinical Research and Nursing
Dr. Howard’s research examines the health service needs of survivors of acute life-threatening illness, specifically cancer and critical illness. She promotes socially responsive scholarship; generating evidence of survivor priorities vital for enhancing the accessibility and quality of health services. The overarching aim of Dr. Howard’s research is to generate patient- and family- perspective evidence of their health and disability challenges as the foundation to designing and evaluating patient-centred healthcare to address the complications of critical illness survivorship and the long-term burden of illness.

Dr. Chris Lovato
Clinical Research and Nursing, Population Health and Cancer Control
I am a Professor in the School of Population & Public Health and Founding Director, Evaluation Studies Unit, Faculty of Medicine, UBC. My primary areas of expertise are in health promotion, population health and program evaluation. My research focuses on evaluating the impact of health programs and policies, particularly in the areas of cancer prevention and health services. I am also conducting studies to evaluate the impact of medical school initiatives implemented in response to health care professional shortages in rural, remote and northern regions of Canada

Dr. Robert Olsen
Clinical Research and Nursing, Population Health and Cancer Control
Dr. Olson is a clinician scientist. He is practicing Radiation Oncologist at the BC Cancer Agency Centre for the North, in Prince George, treating breast, head & neck, and lung cancers, with an interest in stereotactic ablative radiotherapy for oligometastatic disease. His research is focused on Health Services Delivery, including prescribing practices of oncologists, and integrating patient reported outcomes into routine clinical care in order to guide care, quality improvement, and research.